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A B S T R A C T
Background: Myomectomy is best planned and carried out when the uterus is not gravid, as this will increase the chance of a 
normal pregnancy with no complication attributable to the fi broid during pregnancy. However, in the developing parts of the 
globe, especially in Africa where uterine fi broid is most common. Although myomectomy during pregnancy is discouraged, there 
are situations when it becomes inevitable. Aim: The aim of the study was to analyze the outcome of 42 consecutive Cesarean 
myomectomy done under the supervision of a Sabbatical obstetrician and gynaecologist at a district hospital in Nigeria. Subjects 
and Methods: This was a prospective, descriptive study of all patients who underwent Cesarean Myomectomy between 
November 2011 and October 2012 in a Obio Cottage Hospital, Port Harcourt, Nigeria. Myomectomy done at the time of Cesarean  
section (CS). The main outcome measures were number, location, and size of the fi broids removed, intraoperative blood loss, 
intra and post-operative complications, need for blood transfusion, and length of hospital stay. Data was entered into SPSS Vs 16 
software and analysed. T-test was used to compare means and fi shers exact test was carry out associations on non parametric 
data. Level of signifi cance was set at P<0.05. Results: Four Hundred and Fourty Six womens were delivered by Cesarean section 
and 42 of these had Cesarean myomectomy. Between 1 and 23 uterine fi broids were removed from each patient. The biggest 
fi broid was 18 cm in diameter and it weighed 3.8 kg. The mean blood loss was 695.7 mls. (250-1600 mls). There were no signifi cant 
intra-operative complication and the mean length of hospitalization was 4.17 days (2.48). Three patients had one unit of blood 
transfusion while the fourth had seven. One patient had postoperative wound infection two weeks after discharge from the 
hospital. Conclusion: This series has added to the growing evidence of the safety of myomectomy during Cesarean section. 
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INTRODUCTION
Any obstetric surgeon who encounters uterine fibroids 
at the time of doing a Cesarean section will always 
remember the age long teaching that uterine fibroids are 
best avoided during Cesarean section. This teaching was 
however modified by Hawkins and Stallworthy[1] who first 
advocated that myomectomy can be done during Cesarean 
sections in selected cases, especially when the fibroid is 
situated anteriorly in the lower segment and/or on the line 
of incision. In the last decade, many authors have reported 
the outcome of inevitable myomectomy during Cesarean 
sections or their experience with selective Cesarean 
myomectomies.[2,3] More recently, many publications have 
appeared in scientific journals with the clear message 
that myomectomy done at the time of Cesarean section 
may not be as dangerous as once thought,[3-7] is ‘effective 
and safe,[2-6] and that future fertility and or subsequent 
pregnancy outcome were unaffected by it.[8]
There is unanimity that myomectomy is best planned and 
carried out when the uterus is not gravid, as this will increase 
the chance of a normal pregnancy with no complication 
attributable to the fibroid during pregnancy. However, in 
the developing parts of the globe, especially in Africa where 
uterine fibroid is most common, many women commence 
pregnancy without being aware that they have uterine 
fibroids. Even when they were offered myomectomy at an 
earlier time, the fear of possible infertility after surgery or 
the fear of the operation itself may have prevented their 
accepting the procedure.
Most of the published works on this topic have been 
retrospective analysis of cases or descriptive studies. This 
prospective study set to document the outcome of Cesarean 
myomectomy in a district hospital in southern Nigeria during 
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the one year sabbatical deployment of the first author. 
This is a part of a larger prospective case-controlled study 
set to address the contentious issues of the safety of the 
procedure – blood loss, operating time, and complications.
SUBJECTS AND METHODS
This prospective study was done between November 2011 
and October 2012. The setting was the Obio Cottage 
Hospital; a Shell Petroleum Development Company 
supported district hospital with a well-organized and highly 
assessed Community Health Insurance Scheme. The first 
author was on a one year Sabbatical deployment by Shell 
Petroleum Development Company to the district hospital 
to help in ‘capacity building’ and in sustaining the novel 
Community Health Insurance Scheme. He had done a lot of 
work on the topic.
Patients scheduled for either an emergency or elective 
lower segment Cesarean section were counselled for 
the additional procedure of a myomectomy during the 
procedure. After the informed consent, arrangement for 
possible blood transfusion (should this become necessary) 
was made. Ethical permit was obtained from Ethics 
Committee of Obio Cottage Hospital on 12th of October 
2012. Ref. No. Ob.11/12/005. Committee Chairman – Dr. 
F. Anene.
The safe delivery of the baby was always undertaken 
before the myomectomy, even in the very few cases 
where there was/were anterior lower segment fibroid/s. 
In this case, the same incision was utilized for both 
procedures. Following the delivery of the baby, high 
dose oxytocin infusion (30 i.u. in 500 mls) was put up 
and the Cesarean incision closed in two layers before 
myomectomy procedure was carefully undertaken. The 
bilateral uterine artery tourniquet was only resorted to 
if the high dose oxytocin was unable to control bleeding 
during the intra-operative period. The cavities from which 
the fibroids were enucleated were meticulously closed 
using fine absorbable sutures (vicryl/0 or 2/0), with the 
sutures closely applied and in two to four layers. Oxytocin 
infusion was maintained for 24 hrs after surgery at a rate 
of 20 drops/min.
Blood loss was assessed by the Anaesthetist and Operating 
Room Nurse from the suction bottle, weight differentials 
of used swabs and linen. The data collected for each case 
included the number, location and size of the fibroids 
removed, intraoperative blood loss, type of anesthesia, 
duration of operation, need for blood transfusion, intra and 
postoperative complications, and length of hospital stay. 
Data was entered into SPSS Vs 16 software and analysed. 
T-test was used to compare means and fishers exact test 
was carry out associations on non parametric data. Level of 
significance was set at P<0.05.
RESULTS
There were 1939 deliveries and 446 cases of Cesarean 
sections done in the facility during the period of the study. 
75 of these cases (16.8%) were elective. All were done at 
36-41 weeks of gestation. 42 had Cesarean myomectomy. 
The Cesarean section rate for the facility was 23% and the 
Cesarean myomectomy rate was 9.4% of the Cesarean 
sections.
Most of the patients were above 30 years and the commonest 
indications for Cesarean section were Cephalo-Pelvic 
Disproportion/Obstructed Labor, Primigravid Breech and 
Pregnancy-Induced Hypertension [Tables 1 and 2].
Most of the patients had their fibroids in the subserous 
and intramural compartments of the uterus, and most of 
the fibroids were located in the anterior upper segment 
with quite a few on the lower segment and posterior wall. 
Many patients had less than 5 fibroids removed and about 
50% had between 6 and 15 [Table 3]. The highest number 
removed was 23 and the largest size was 18 cm in diameter. 
This fibroid weighed 3.8 kg!
High dose Oxytocin infusion was the main technique 
for limiting bleeding during the procedures; only in one 
case was the bilateral uterine artery tourniquet utilized. 
The blood loss in this series is reflected in Table 4. 
Seven patients lost over 800 mls of blood. However, 
none had a loss severe enough and/or unresponsive to 
simple replacement to necessitate a hysterectomy. The 
Table 1: Age and parity of patients







5 and above 2 (4.8)
Table 2: Indications for cesarean section
Indication Number %
Two or more previous C/S 1 2.4
Cephalo-pelvic disproportion/obstructed labor 10 23.8
Primigravid breech 8 19.1
Previous C/S+another indication 3 7.1
Failed induction of labour 4 9.5
Pregnancy induced hypertension 5 11.9
Unstable/transverse lie 3 7.1
Elderly primip+previous infertility 4 9.5
Patients’ request 2 4.8
Placenta previa 2 4.8
Total 42 100
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haematocrit deficits (the difference between the pre-op and 
second day post-op values) are also reflected in Table 4. 
Three patients needed one unit of blood replacement but 
one patient had seven units. This patient had the additional 
pathology of adenomyosis and had uterine atony after 
she was discharged to the ward from the recovery room. 
We found no relationship between the number of fibroids 
removed and the blood loss.
The patient who had 7 units of blood had seven fibroids 
removed (largest was 5 cm) and also had extensive 
adenomyosis. She had uterine atony.
The duration of surgery was less than 60 mins in more than half 
of the cases and the two cases that lasted more than 90 mins 
were the cases with the most fibroids. More than half of the 
patients spent between 2-3 days before discharge. The five 
patients who spent more than five days had delayed wound 
healing. They all had emergency lower segment Cesarean 
section for obstructed labour. One of the early discharges was 
readmitted after two weeks with delayed wound infection.
DISCUSSION
Myomectomy during Cesarean section has traditionally 
been discouraged. In fact, many surgeons perform classical 
Cesarean instead of a low transverse Cesarean in order 
to avoid a lower uterine segment uterine fibroid, even 
though the procedure carries more risk of increased 
blood loss in itself. The aim is for an interval myomectomy 
later.[8] In the last decade, however, many authors have 
reported myomectomy during Cesarean section for specific 
indications like pedunculated fibroids or when myomectomy 
was considered ‘unavoidable.[9] More recently, reports 
about the routine removal of all fibroids, especially those 
in the anterior wall of the uterus, have been reported.[4,10,11]
Interestingly, some authors have reported a higher incidence 
of post-partum haemorrhage, some life-threatening, 
in cases where the fibroid/s (especially when in the 
lower uterine segment) is/are not removed at Cesarean 
section.[12,13] However, the advantages of this procedure to 
the woman, especially the avoidance of a repeat laparotomy 
and anaesthesia with their complications[14] and the cost 
saving[7] are attractive to many women and doctors, 
especially in low resource countries, must be emphasised.
The most contentious issue with this controversial 
procedure is the blood loss. The average loss at Cesarean 
section is put at 1000 mls.[15] More than half of the patients 
in this series recorded a loss of less than 800 mls. Only 
4 patients needed blood replacement, with only one 
requiring more than one unit of blood.
This series has shown that even very huge fibroids can safely 
be removed at Cesarean section. About 25% of the patients 
had fibroids measuring 10 cm and above removed, with the 
largest weighing 3.8 kg and measuring 23 cm in diameter! 
These big fibroids, if left in situ during the Cesarean section, 
were capable of preventing effective uterine contractions 
with the resultant complications of uterine atony and 
sub-involution. Additionally, their removal decreases 
the complications associated with uterine fibroids in 
subsequent pregnancies.[16] The scar integrity following 
Cesarean myomectomy has been shown to be better than 
that following interval myomectomy[17,18] when assessed 
Table 3: Number, sizes of uterine fibroids, and their 
location in the uterus
Number of patients





Size of fi broids









Location of fi broid/s
Mainly in the upper segment 31
Mainly in the lower segment 11
Mainly in the anterior wall 32
Mainly in the posterior wall 10
The highest number removed was 23 the largest size was 18 cm. This fi broid weighed 3.8 kg!







1101 and above 4 (9.5)
Mean=695.7 mls (250-1600 mls)




Above 90 mins 2 (4.8)




Above 7 days 3 (7.1)
Mean=4.17 days (SD=2.48)




10 and above 7 (16.7)
Blood transfusion* No. of patients
One unit 3
Seven units 1
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with serial ultrasound scan in subsequent pregnancies[17] 
and at subsequent Cesarean section.[18]
An interesting finding in this series is the request by two 
patients for elective Cesarean myomectomy. They were 
both obliged, in line with the growing trend of granting 
elective Cesarean section requests. In a large, multiunit 
study, 15-79% of European obstetricians obliged the 
woman’s request for an elective Cesarean section because 
that was ‘her choice’. That study concluded that, until 
better evidence becomes available, individual obstetricians 
faced with a request for elective Cesarean delivery are 
charged with the delicate task of fostering their patients’ 
freedom of choice by exploring the motivation and fears 
underlying such requests and ultimately act according to 
what they believe to better promote the health and welfare 
of mother and fetus.[19]
The lengths of hospital stay of the Cesarean myomectomy 
patients were normal for Cesarean section and the morbidity 
encountered in this series fell within the expected level.
CONCLUSION
The results of this study are further convincing evidence 
that Cesarean myomectomy may not be as dangerous as 
once thought.
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